multiple sclerosis
The findings suggest that bHB could be a therapeutic alternative to a ketogenic diet. The results also highlight the protective role of the gut microbiota and its metabolites in autoimmune…
A significant milestone for both microbiome research and neurodegenerative diseases.
ETX-producing C. perfringens strains are biologically plausible pathogens in MS that trigger inflammatory demyelination.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, spoke about how the research in gut-brain axes could pave the way to new microbiome based therapies in neurodegenerative diseases.
The findings of a new research shed light on the mechanisms by which gut bacteria influence the development and progression of multiple sclerosis.
An isoflavone diet enables the proliferation of specific gut bacteria that can improve multiple scleroris disease outcomes.
IL-17 molecules from the gut can influence autoimmune diseases in the central nervous system by regulating the gut microbiota.
People with active multiple sclerosis have high levels of particular gut antibodies, called immunoglobulin A (IgA), in the central nervous systems.
According to a recent study, the gut microbiota could determine remittance or pro-inflammatory conditions in multiple sclerosis.
GDP-L-fucose synthase, a protein produced by bacteria often found in the gut of people with MS, triggers an autoimmune response from T-cells in MS patients.
